THY1 and nephritis: As early as 1999, Tammo Ostendorf et al applied VEGFA‐antagonist to anti‐Thy‐1 nephritis, which though effectively inhibited ECs proliferation, inhibited ECs restoration and increased ECs death at the same time.38